Download Library

Date Document Type

2018 J.P. Morgan Healthcare Conference

SNO 2017 Radio-chemo-immunotherapy using the IDO-inhibitor indoximod for childhood brain cancer

Corporate Presentation November 2017

TCH 2017 Radio-chemo-immunotherapy using the IDO-inhibitor indoximod for childhood brain cancer

CIC 2017 Indoximod Plus KEYTRUDA (pembrolizumab) Phase 2

EHA 2017 <strong>Phase I Indoximod plus Idarubicin &amp; Cytarabine for Newly Diagnosed Acute Myeloid Leukemia</strong>

ASCO 2017 <strong>Phase II Double-blind study of Metastatic Castration-resistant Prostate Cancer</strong>

AACR 2017 <strong>NLG802 Prodrug Poster Presentation</strong>

AACR Plenary 2017 <strong>Indoximod plus Keytruda (pembrolizumab) Phase II Interim in Advanced Melanoma</strong>

SNO 2016 <strong>Indoximod + Temozolomide Brain Tumor Trial</strong>